Phase I/II Trial of Clofarabine and Cytarabine in Children With Relapsed/Refractory Acute Lymphoblastic Leukemia (AAML0523): A Report From the Children’s Oncology Group

BACKGROUND: The discovery of effective re-induction regimens for children with more than one relapse of acute lymphoblastic leukemia (ALL) remains elusive. The novel nucleoside analog clofarabine exhibits modest single agent efficacy in relapsed ALL, though optimal combinations of this agent with ot...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pediatr Blood Cancer
Egile Nagusiak: Cooper, Todd M., Razzouk, Bassem I., Gerbing, Robert, Alonzo, Todd A., Adlard, Kathleen, Raetz, Elizabeth, Gamis, Alan S., Perentesis, John, Whitlock, James A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4605828/
https://ncbi.nlm.nih.gov/pubmed/23335239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24398
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak